Search projects

MiBiPa - Non-invasive microbiome-derived multi-omic biomarker...

ELU-1-913FE2-1

Parkinson’s disease (PD) research benefits from knowledge of disease-specific risk and resilience factors and elucidation of pathophysiological concepts on the emergence of neurodegeneration. Presently the propagation of a-synuclein aggregation in PD is proposed to start in the periphery, i.e. in the enteric nervous system and the olfactory bulb. Aberrations within the gastrointestinal and nasal microbiomes may play a role in the initiation of this process. This is of particular relevance in...

Keywords: Parkinson’s disease microbiome biomarker